Roles of microRNA-206 in Osteosarcoma Pathogenesis and Progression |
Bao, Yun-Ping
(Medical School of Yangtze University, The First People's Hospital of Jingzhou)
Yi, Yang (Department of Orthopedics, The First People's Hospital of Jingzhou) Peng, Li-Lin (Department of Orthopedics, The First People's Hospital of Jingzhou) Fang, Jing (Department of Neurology, The Second People's Hospital of Jingzhou) Liu, Ke-Bin (Department of Orthopedics, The First People's Hospital of Jingzhou) Li, Wu-Zhou (Department of Orthopedics, The First People's Hospital of Jingzhou) Luo, Hua-Song (Department of Orthopedics, The First People's Hospital of Jingzhou) |
1 | Alley MC, Scudiero DA, Monks A, et al (1988). Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res, 48, 589-601. |
2 | Ambros V (2003). MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell, 113, 673-6. DOI ScienceOn |
3 | Bartel DP, and Chen CZ (2004). Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat Rev Genet, 5, 396-400. |
4 | Calin GA, Dumitru CD, Shimizu M, et al (2002). Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A, 99, 15524-9. DOI ScienceOn |
5 | Calin GA, Sevignani C, Dumitru CD, et al (2004). Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A, 101, 2999-3004. DOI ScienceOn |
6 | Casalini P, and Iorio MV (2009). MicroRNAs and future therapeutic applications in cancer. J Buon, 14, S17-22. |
7 | Chen X, Yan Q, Li S, et al (2012). Expression of the tumor suppressor miR-206 is associated with cellular proliferative inhibition and impairs invasion in ERalpha-positive endometrioid adenocarcinoma. Cancer Lett, 314, 41-53. DOI ScienceOn |
8 | Cho Y, Jung GH, Chung SH, et al (2011). Long-term survivals of stage IIb osteosarcoma: a 20-year experience in a single institution. Clin Orthop Surg, 3, 48-54. DOI ScienceOn |
9 | Fabian MR, and Sonenberg N (2012). The mechanics of miRNAmediated gene silencing: a look under the hood of miRISC. Nat Struct Mol Biol, 19, 586-93. DOI ScienceOn |
10 | Geller DS, and Gorlick R (2010). Osteosarcoma: a review of diagnosis, management, and treatment strategies. Clin Adv Hematol Oncol, 8, 705-18. |
11 | Iorio MV, Ferracin M, Liu CG, et al (2005). MicroRNA gene expression deregulation in human breast cancer. Cancer Res, 65, 7065-70. DOI ScienceOn |
12 | Jovanovic M, and Hengartner MO (2006). miRNAs and apoptosis: RNAs to die for. Oncogene, 25, 6176-87. DOI ScienceOn |
13 | Kobayashi E, Hornicek FJ, and Duan Z (2012). MicroRNA Involvement in Osteosarcoma. Sarcoma, 2012, 359739. |
14 | Kondo N, Toyama T, Sugiura H, et al (2008). miR-206 Expression is down-regulated in estrogen receptor alphapositive human breast cancer. Cancer Res, 68, 5004-8. DOI ScienceOn |
15 | Krek A, Grun D, Poy MN, et al (2005). Combinatorial microRNA target predictions. Nat Genet, 37, 495-500. DOI ScienceOn |
16 | Leivonen SK, Makela R, Ostling P, et al (2009). Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines. Oncogene, 28, 3926-36. DOI ScienceOn |
17 | Lewis VO (2009). What’s new in musculoskeletal oncology. J Bone Joint Surg Am, 91, 1546-56. DOI ScienceOn |
18 | Liu ZY, Zhang GL, Wang MM, et al (2011). MicroRNA-663 targets TGFB1 and regulates lung cancer proliferation. Asian Pac J Cancer Prev, 12, 2819-23. |
19 | Marina N, Gebhardt M, Teot L, and Gorlick R (2004). Biology and therapeutic advances for pediatric osteosarcoma. Oncologist, 9, 422-41. DOI ScienceOn |
20 | Missiaglia E, Shepherd CJ, Patel S, et al (2010). MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas. Br J Cancer, 102, 1769-77. DOI ScienceOn |
21 | Miyachi M, Tsuchiya K, Yoshida H, et al (2010). Circulating muscle-specific microRNA, miR-206, as a potential diagnostic marker for rhabdomyosarcoma. Biochem Biophys Res Commun, 400, 89-93. DOI ScienceOn |
22 | Schmittgen TD, and Livak KJ (2008). Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc, 3, 1101-8. DOI ScienceOn |
23 | Song G, Zhang Y, and Wang L (2009). MicroRNA-206 targets notch3, activates apoptosis, and inhibits tumor cell migration and focus formation. J Biol Chem, 284, 31921-7. DOI ScienceOn |
24 | Song T, Xia W, Shao N, et al (2010). Differential miRNA expression profiles in bladder urothelial carcinomas. Asian Pac J Cancer Prev, 11, 905-11. |
25 | Taulli R, Bersani F, Foglizzo V, et al (2009). The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation. J Clin Invest, 119, 2366-78. |
26 | Vickers MM, Bar J, Gorn-Hondermann I, et al (2012). Stagedependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic disease. Clin Exp Metastasis, 29, 123-32. DOI ScienceOn |
27 | Wang X, Ling C, Bai Y, and Zhao J (2011). MicroRNA-206 is associated with invasion and metastasis of lung cancer. Anat Rec, 294, 88-92. DOI ScienceOn |
28 | Zhang T, Liu M, Wang C, et al (2011). Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression. Anticancer Res, 31, 3859-63. |
![]() |